Bybit Partners with XAUE Protocol to Offer 2.83% Fixed APR on XAUT Savings

DUBAI, UAE, Oct. 27, 2026 /PRNewswire/ — Bybit, the New Financial Platform…

How to Care for Caregivers? NCCN Debuts Essential Guide for Supporting Loved Ones with Cancer

New, free book offers simple but empowering information on how to care…

Levoit Eleva™ Series HEPA Air Purifiers Debut as Fully Sealed Systems for Allergen Defense

Eleva 500X leads the series with multi-channel pollutant detection for large rooms;…

Solace Fall 2026 Edition Gives AI Agents the Real-Time Data and Controls Needed for Production and Scale

New platform capabilities stream real-time data intelligently and give agents the governance…

Yuchai Strengthens African Continent Coverage

SINGAPORE, Oct. 27, 2026 /PRNewswire/ — China Yuchai International Limited (NYSE: CYD)…

Asia Poised to Play Bigger Role in Physical AI as Investors Eye Manufacturing, Data

SAN FRANCISCO, Oct. 27, 2026 /PRNewswire/ — Asia’s semiconductor expertise, manufacturing infrastructure…

KESUMA SPREADS DEEPAVALI CHEER THROUGH THE DISTRIBUTION OF 22,000 MADANI ESSENTIAL GOODS PACKAGES

KUALA LUMPUR, PETALING JAYA, Malaysia and SINGAPORE, Oct. 28, 2026 /PRNewswire/ —…

New Indication Application for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Accepted for Review by NMPA

This is the seventh indication application for sacituzumab tirumotecan (sac-TMT) and the…